Global Renal Anemia Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	160 Pages	TechNavio	January, 2024	INF18413880

Best Price Guarantee
Price	from $2,500
Length	160 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18413880

Global Renal Anemia Therapeutics Market 2024-2028

The renal anemia therapeutics market is forecasted to grow by USD 2.08 bn during 2023-2028, accelerating at a CAGR of 7.59% during the forecast period. The report on the renal anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by presence of large pool of CKD patients, growing geriatric population, and new drug approvals for renal anemia therapeutics.

Technavio's renal anemia therapeutics market is segmented as below:

By Type

IV
Oral

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing adoption of biosimilars as one of the prime reasons driving the renal anemia therapeutics market growth during the next few years. Also, the growing emphasis on personalized and precision medicine in nephrology and the rising number of renal anemia therapeutic drugs in the pipeline will lead to sizable demand in the market.

The report on the renal anemia therapeutics market covers the following areas:

Renal anemia therapeutics market sizing
Renal anemia therapeutics market forecast
Renal anemia therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading renal anemia therapeutics market vendors that include Akebia Therapeutics Inc., Amgen Inc., AstraZeneca Plc, Bayer AG, Covis Pharma GmbH, CSL Ltd., Daiichi Sankyo Co. Ltd., Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., FibroGen Inc., GlaxoSmithKline Plc, Japan Tobacco Inc., JCR Pharmaceticals Co. Ltd., Kirin Holdings Co. Ltd., Mitsubishi Chemical Group Corp., Pfizer Inc., Pharmacosmos AS, Sun Pharmaceutical Industries Ltd., Travere Therapeutics Inc., and Astellas Pharma Inc.. Also, the renal anemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global renal anemia therapeutics market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global renal anemia therapeutics market 2018 - 2022 ($ billion); 4.2 Type Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.3 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 30: Chart on Type - Market share 2023-2028 (%); Exhibit 31: Data Table on Type - Market share 2023-2028 (%); 6.2 Comparison by Type; Exhibit 32: Chart on Comparison by Type; Exhibit 33: Data Table on Comparison by Type; 6.3 IV - Market size and forecast 2023-2028; Exhibit 34: Chart on IV - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on IV - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on IV - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on IV - Year-over-year growth 2023-2028 (%); 6.4 Oral - Market size and forecast 2023-2028; Exhibit 38: Chart on Oral - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Oral - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Type; Exhibit 42: Market opportunity by Type ($ billion); Exhibit 43: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Distribution Channel: 7.1 Market segments; Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%); 7.2 Comparison by Distribution Channel; Exhibit 46: Chart on Comparison by Distribution Channel; Exhibit 47: Data Table on Comparison by Distribution Channel; 7.3 Hospital pharmacy - Market size and forecast 2023-2028; Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); 7.4 Retail pharmacy - Market size and forecast 2023-2028; Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); 7.5 Online pharmacy - Market size and forecast 2023-2028; Exhibit 56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); 7.6 Market opportunity by Distribution Channel; Exhibit 60: Market opportunity by Distribution Channel ($ billion); Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 China - Market size and forecast 2023-2028; Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 UK - Market size and forecast 2023-2028; Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.11 Canada - Market size and forecast 2023-2028; Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ billion); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion); 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends; 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business; 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 Akebia Therapeutics Inc.; Exhibit 111: Akebia Therapeutics Inc. - Overview; Exhibit 112: Akebia Therapeutics Inc. - Product / Service; Exhibit 113: Akebia Therapeutics Inc. - Key offerings; 12.4 Amgen Inc.; Exhibit 114: Amgen Inc. - Overview; Exhibit 115: Amgen Inc. - Product / Service; Exhibit 116: Amgen Inc. - Key offerings; 12.5 AstraZeneca Plc; Exhibit 117: AstraZeneca Plc - Overview; Exhibit 118: AstraZeneca Plc - Product / Service; Exhibit 119: AstraZeneca Plc - Key news; Exhibit 120: AstraZeneca Plc - Key offerings; 12.6 Bayer AG; Exhibit 121: Bayer AG - Overview; Exhibit 122: Bayer AG - Business segments; Exhibit 123: Bayer AG - Key news; Exhibit 124: Bayer AG - Key offerings; Exhibit 125: Bayer AG - Segment focus; 12.7 Covis Pharma GmbH; Exhibit 126: Covis Pharma GmbH - Overview; Exhibit 127: Covis Pharma GmbH - Product / Service; Exhibit 128: Covis Pharma GmbH - Key offerings; 12.8 Daiichi Sankyo Co. Ltd.; Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview; Exhibit 130: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news; Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings; 12.9 Dr Reddys Laboratories Ltd.; Exhibit 133: Dr Reddys Laboratories Ltd. - Overview; Exhibit 134: Dr Reddys Laboratories Ltd. - Business segments; Exhibit 135: Dr Reddys Laboratories Ltd. - Key offerings; Exhibit 136: Dr Reddys Laboratories Ltd. - Segment focus; 12.10 F. Hoffmann La Roche Ltd.; Exhibit 137: F. Hoffmann La Roche Ltd. - Overview; Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 139: F. Hoffmann La Roche Ltd. - Key news; Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus; 12.11 GlaxoSmithKline Plc; Exhibit 142: GlaxoSmithKline Plc - Overview; Exhibit 143: GlaxoSmithKline Plc - Business segments; Exhibit 144: GlaxoSmithKline Plc - Key news; Exhibit 145: GlaxoSmithKline Plc - Key offerings; Exhibit 146: GlaxoSmithKline Plc - Segment focus; 12.12 Japan Tobacco Inc.; Exhibit 147: Japan Tobacco Inc. - Overview; Exhibit 148: Japan Tobacco Inc. - Business segments; Exhibit 149: Japan Tobacco Inc. - Key news; Exhibit 150: Japan Tobacco Inc. - Key offerings; Exhibit 151: Japan Tobacco Inc. - Segment focus; 12.13 JCR Pharmaceticals Co. Ltd.; Exhibit 152: JCR Pharmaceticals Co. Ltd. - Overview; Exhibit 153: JCR Pharmaceticals Co. Ltd. - Product / Service; Exhibit 154: JCR Pharmaceticals Co. Ltd. - Key offerings; 12.14 Kirin Holdings Co. Ltd.; Exhibit 155: Kirin Holdings Co. Ltd. - Overview; Exhibit 156: Kirin Holdings Co. Ltd. - Business segments; Exhibit 157: Kirin Holdings Co. Ltd. - Key offerings; Exhibit 158: Kirin Holdings Co. Ltd. - Segment focus; 12.15 Mitsubishi Chemical Group Corp.; Exhibit 159: Mitsubishi Chemical Group Corp. - Overview; Exhibit 160: Mitsubishi Chemical Group Corp. - Business segments; Exhibit 161: Mitsubishi Chemical Group Corp. - Key offerings; Exhibit 162: Mitsubishi Chemical Group Corp. - Segment focus; 12.16 Pfizer Inc.; Exhibit 163: Pfizer Inc. - Overview; Exhibit 164: Pfizer Inc. - Product / Service; Exhibit 165: Pfizer Inc. - Key news; Exhibit 166: Pfizer Inc. - Key offerings; 12.17 Sun Pharmaceutical Industries Ltd.; Exhibit 167: Sun Pharmaceutical Industries Ltd. - Overview; Exhibit 168: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibit 169: Sun Pharmaceutical Industries Ltd. - Key offerings; 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 170: Inclusions checklist; Exhibit 171: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 172: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 173: Research methodology; Exhibit 174: Validation techniques employed for market sizing; Exhibit 175: Information sources; 13.5 List of abbreviations; Exhibit 176: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global renal anemia therapeutics market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Type - Market share 2023-2028 (%); Exhibits31: Data Table on Type - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Type; Exhibits33: Data Table on Comparison by Type; Exhibits34: Chart on IV - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on IV - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on IV - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on IV - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Oral - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Oral - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Oral - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Oral - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by Type ($ billion); Exhibits43: Data Table on Market opportunity by Type ($ billion); Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits46: Chart on Comparison by Distribution Channel; Exhibits47: Data Table on Comparison by Distribution Channel; Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits52: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits57: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits58: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits60: Market opportunity by Distribution Channel ($ billion); Exhibits61: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits103: Market opportunity By Geographical Landscape ($ billion); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits105: Impact of drivers and challenges in 2023 and 2028; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: Akebia Therapeutics Inc. - Overview; Exhibits112: Akebia Therapeutics Inc. - Product / Service; Exhibits113: Akebia Therapeutics Inc. - Key offerings; Exhibits114: Amgen Inc. - Overview; Exhibits115: Amgen Inc. - Product / Service; Exhibits116: Amgen Inc. - Key offerings; Exhibits117: AstraZeneca Plc - Overview; Exhibits118: AstraZeneca Plc - Product / Service; Exhibits119: AstraZeneca Plc - Key news; Exhibits120: AstraZeneca Plc - Key offerings; Exhibits121: Bayer AG - Overview; Exhibits122: Bayer AG - Business segments; Exhibits123: Bayer AG - Key news; Exhibits124: Bayer AG - Key offerings; Exhibits125: Bayer AG - Segment focus; Exhibits126: Covis Pharma GmbH - Overview; Exhibits127: Covis Pharma GmbH - Product / Service; Exhibits128: Covis Pharma GmbH - Key offerings; Exhibits129: Daiichi Sankyo Co. Ltd. - Overview; Exhibits130: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits131: Daiichi Sankyo Co. Ltd. - Key news; Exhibits132: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits133: Dr Reddys Laboratories Ltd. - Overview; Exhibits134: Dr Reddys Laboratories Ltd. - Business segments; Exhibits135: Dr Reddys Laboratories Ltd. - Key offerings; Exhibits136: Dr Reddys Laboratories Ltd. - Segment focus; Exhibits137: F. Hoffmann La Roche Ltd. - Overview; Exhibits138: F. Hoffmann La Roche Ltd. - Business segments; Exhibits139: F. Hoffmann La Roche Ltd. - Key news; Exhibits140: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits141: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits142: GlaxoSmithKline Plc - Overview; Exhibits143: GlaxoSmithKline Plc - Business segments; Exhibits144: GlaxoSmithKline Plc - Key news; Exhibits145: GlaxoSmithKline Plc - Key offerings; Exhibits146: GlaxoSmithKline Plc - Segment focus; Exhibits147: Japan Tobacco Inc. - Overview; Exhibits148: Japan Tobacco Inc. - Business segments; Exhibits149: Japan Tobacco Inc. - Key news; Exhibits150: Japan Tobacco Inc. - Key offerings; Exhibits151: Japan Tobacco Inc. - Segment focus; Exhibits152: JCR Pharmaceticals Co. Ltd. - Overview; Exhibits153: JCR Pharmaceticals Co. Ltd. - Product / Service; Exhibits154: JCR Pharmaceticals Co. Ltd. - Key offerings; Exhibits155: Kirin Holdings Co. Ltd. - Overview; Exhibits156: Kirin Holdings Co. Ltd. - Business segments; Exhibits157: Kirin Holdings Co. Ltd. - Key offerings; Exhibits158: Kirin Holdings Co. Ltd. - Segment focus; Exhibits159: Mitsubishi Chemical Group Corp. - Overview; Exhibits160: Mitsubishi Chemical Group Corp. - Business segments; Exhibits161: Mitsubishi Chemical Group Corp. - Key offerings; Exhibits162: Mitsubishi Chemical Group Corp. - Segment focus; Exhibits163: Pfizer Inc. - Overview; Exhibits164: Pfizer Inc. - Product / Service; Exhibits165: Pfizer Inc. - Key news; Exhibits166: Pfizer Inc. - Key offerings; Exhibits167: Sun Pharmaceutical Industries Ltd. - Overview; Exhibits168: Sun Pharmaceutical Industries Ltd. - Product / Service; Exhibits169: Sun Pharmaceutical Industries Ltd. - Key offerings; Exhibits170: Inclusions checklist; Exhibits171: Exclusions checklist; Exhibits172: Currency conversion rates for US$; Exhibits173: Research methodology; Exhibits174: Validation techniques employed for market sizing; Exhibits175: Information sources; Exhibits176: List of abbreviations